Mural Oncology plc
Mural Oncology plc (MURA) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
mura · pe ratio · data through Dec 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Mural Oncology plc (MURA) measures how much investors pay for each dollar of the company's trailing earnings. MURA's current PE ratio of N/A is calculated by dividing its stock price of $2.04 by its TTM earnings per share of -$6.88.
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31
PE Ratio History
2021 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Mural Oncology plcYou MURA | $35M | N/A | — | -$6.88 |
 Alterity Therapeutics Limited ATHE | $36M | N/A | — | -$1.14 |
 BioAtla, Inc. BCAB | $4M | N/A | — | -$50.66 |
 BioXcel Therapeutics, Inc. BTAI | $34M | N/A | — | -$5.73 |
 Evaxion Biotech A/S EVAX | $24M | N/A | — | -$1.20 |
 Generation Bio Co. GBIO | $36M | N/A | — | -$19.76 |
 Jasper Therapeutics, Inc. JSPR | $8M | N/A | — | -$3.95 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-12-31Latest FY2024 | — | $-7.58 | — | |
2023-12-31 FY2023 | — | $-12.43 | — | |
2022-12-31 FY2022 | — | $-11.37 | — | |
2021-12-31 FY2021 | — | $-10.51 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Mural Oncology plc (MURA) measures how much investors pay for each dollar of the company's trailing earnings. MURA's current PE ratio of N/A is calculated by dividing its stock price of $2.04 by its TTM earnings per share of -$6.88.
Frequently asked questions
MURA pe ratio · 6 questionsMURA's current PE ratio is N/A as of 2026-06-09, based on a stock price of $2.04 and TTM EPS of -$6.88. Data sourced from Financial Modeling Prep via MURA's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Mural Oncology plc SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09